| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1378
|
23.50 | 230.8B | 2.10 | 1.49 | 1.27 | 23.1% | 9.1% | 87 | 83 | 64.94 | +132.3% | 84 | 0.44 |
|
3858
|
62.90 | 28.7B | 3.88 | 9.10 | 2.79 | 94.2% | 11.1% | 81 | 83 | 126.68 | +76.1% | 95 | 0.32 |
|
3330
|
22.24 | 26.6B | 3.60 | 3.26 | 2.32 | 26.8% | 10.5% | 78 | 79 | 44.84 | +76.2% | 75 | 0.49 |
|
2233
|
1.97 | 10.8B | 5.27 | 0.74 | 2.18 | 4.6% | 8.3% | 77 | 62 | 4.99 | +114.7% | 63 | 0.92 |
|
1286
|
8.63 | 16.8B | 5.25 | 2.50 | 2.99 | 10.5% | 10.5% | 75 | 63 | 16.69 | +70.0% | 75 | 0.37 |
|
0340
|
3.31 | 17.6B | 4.35 | 3.61 | 2.65 | — | — | 73 | 52 | 5.97 | +55.6% | 98 | 0.15 |
|
1208
|
9.23 | 118.6B | 27.81 | 2.64 | 6.55 | 49.3% | 10.1% | 53 | 73 | 7.70 | -12.4% | 97 | 0.09 |
|
3939
|
15.30 | 67.7B | 10.20 | 11.97 | 6.20 | 68.7% | 11.3% | 49 | 57 | 10.61 | -23.0% | 99 | 0.02 |
|
1258
|
16.56 | 64.6B | 28.11 | 2.99 | 11.57 | 36.3% | 11.3% | 43 | 62 | 9.91 | -30.1% | 100 | 0.00 |
|
2259
|
152.00 | 406.8B | 40.17 | 5.56 | 21.12 | 37.2% | 9.8% | 43 | 66 | 85.56 | -32.8% | 100 | 0.01 |
|
2099
|
256.20 | 101.6B | 32.80 | 4.92 | 23.41 | 29.9% | 10.3% | 37 | 51 | 104.02 | -44.5% | 100 | 0.02 |
|
1164
|
2.62 | 20.0B | 11.33 | 4.46 | 40.21 | 2.0% | 10.6% | 34 | 23 | 1.51 | -28.4% | 57 | 0.57 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.